Literature DB >> 3005438

Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients.

L Kitchen, G Malone, S Orgad, F Barin, R Zaizov, B Ramot, E Gazit, J Kreiss, M Leal, I Wichmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005438     DOI: 10.1093/infdis/153.4.788

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

Authors:  J M Lange; D A Paul; H G Huisman; F de Wolf; H van den Berg; R A Coutinho; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

2.  Use of TrpE/Gag fusion proteins to characterize immunoreactive domains on the human immunodeficiency virus type 1 core protein.

Authors:  M G Windheuser; G E Tegtmeier; C Wood
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

3.  Investigation of atypical western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type.

Authors:  S L Josephson; N S Swack; M T Ramirez; W J Hausler
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

4.  Patterns of antigenaemia and antibody response in patients infected with human immunodeficiency virus (HIV) according to clinical state.

Authors:  M C Re; G Furlini; M La Placa
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

5.  Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody.

Authors:  R M Thorn; G A Beltz; C H Hung; B F Fallis; S Winkle; K L Cheng; D J Marciani
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

6.  Enzyme immunoassay using native envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies.

Authors:  B C Nair; G Ford; V S Kalyanaraman; M Zafari; C Fang; M G Sarngadharan
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.